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available at the end of the articleRobert Heinlein gave the following background for his story of the same name. “When
we were living in Colorado there was snowfall. Our cat wanted to get out of the house
so I opened a door for him but he wouldn’t leave. Just kept on crying. He’d seen snow
before and I couldn’t understand it. I kept opening other doors for him and he still
wouldn’t leave. Then Ginny [his wife] said, ‘Oh, he’s looking for a door into summer.’”
Innovation and discovery in science is often like this: elemental but not obvious. It has
these two other properties, things it shares with interestingness: does the initial insight
identify deep ignorance, and, are we willing to hike for a long time down that trail to
validate the results?
A new domain or continent is likely to have been discovered when, standing on the
shore or on the first hill, it seems to extend to the horizon, new in every large and tiny
respect, each tree, moss, flying thing unknown to us, while likely easily known to others
whom we’ve not met. This immediate sense of deep ignorance should be a confirming
property of something most interesting. When the mu meson particle was first discov-
ered in 1936, it arrived with amazing and unexpected properties. At a time when particle
physics seemed to be a settled topic, it startled the physics community: the (later) Nobel
winning physicist I. I. Rabi, was quoted as saying “Who ordered that?” Deep ignorance
and surprise can be taken as reliable markers for valuable outcomes and most interesting
results.
But confirming and getting to an understanding of the new result—the muon as it
came to be known and many other new particles—took years. It wasn’t until the mid-1970s
that these finally were organized as the Standard Model, and then was completed only in
2012 by experimental verification of the Higgs boson. So, novelty is curiously most valuable
when it has been thoroughly rendered as Standard and this is unavoidably a long arduous
process. Discovery is not for the comfortable, requires a league of collaborators, and it
might feel, requires all the time in the world. Such is the nature of biomedical research.
These anecdotes are relevant to the science of biological data mining that is often
dominated by simple measures of model interestingness such as accuracy, area under
the receiver operating characteristic (ROC) curve, or p-value. While important, these
measures only imply a fraction of a model’s story, as shown by the extensive review of
Geng and Hamilton [1]. Nine different measures of interestingness are summarized.
The first is conciseness or parsimony. The second is coverage: does it apply to a broad
portion of the data. The third is reliability, measured by the accuracy or error of a classi-
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novelty: is the result new? The seventh is surprisingness, as measured by how unexpected
the result is based on existing knowledge. The eighth is utility, that is, how useful is the re-
sult. The final criterion is actionability, measuring how applicable a result is to a particular
domain.
Each of these criteria can be grouped into objective and subjective categories. For ex-
ample, conciseness, coverage, reliability peculiarity and diversity are all objective measures
because they can be computed using an algorithm or mathematical function. On the other
hand, novelty, surprisingness, utility and actionability are all subjective and dependent on
the experience and knowledge of the particular domain expert.
Biological data mining is about finding interesting patterns in big data. As with the
muon, we need to move beyond settled notions that still dominate data mining, such
as measures of reliability. It is only one of many signs and signatures that can announce
and advance innovation, can identify the new door, the next new continent.
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